Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SERA PROGNOSTICS, INC. Director's Dealing 2022

Jan 4, 2022

34084_dirs_2022-01-04_44aa73a0-e544-4e8d-a714-203be39fa46e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2021-12-30

Reporting Person: Foley Michael R (Chief Medical Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $1.77 2030-08-20 Class A Common Stock (9620.0) Direct

Footnotes

F1: These stock options vest over two years as follows: 1/24 of the original grant amount vests in monthly installments for two years following the vesting commencement date, which is May 18, 2020.